Target intelligence / Profile preview

Calcium homeostasis modulator protein 3 (CALHM3)

Target
CALHM3
Molecular classification
Ion channel, Voltage-gated ion channel
01

Overview

Calcium homeostasis modulator protein 3 (CALHM3) is a pore-forming subunit of a voltage-gated ion channel, best known for its essential role in the sensory perception of sweet, bitter, and umami tastes[3][4][5][6]. CALHM3 is co-expressed with CALHM1 in type II taste bud cells, where the two proteins assemble into a hetero-hexameric channel complex that functions as a fast-activating, voltage-gated ATP-release channel[4][6]. This ATP release is critical for activating afferent neural gustatory pathways during taste transduction. CALHM3 alone or with CALHM1 is predicted to mediate monoatomic cation (such as Ca²⁺ and Na⁺) flux across the plasma membrane and is mainly localized to the basolateral plasma membrane of taste cells[2][3][5][6]. While primarily studied in the context of taste, CALHM family channels have also been implicated in neuronal excitability and certain neurological pathologies, though direct evidence for CALHM3’s involvement in diseases (such as Alzheimer's or depression) is sparse, with stronger evidence for family members such as CALHM1[1][6]. No drugs, therapeutic mechanisms, or established biomarker roles are currently reported for CALHM3 specifically.

Other names
Calcium homeostasis modulator 3FAM26AbA225H22.7Protein Afamily with sequence similarity 26, member A
02

Biological functions

ATP releaseSensory perception of tasteIon transport (monoatomic cation channel activity)Neuronal excitability
03

Disease associations

Neurological conditions (taste disorders)Related to (but not causative for) Osteogenesis imperfecta, type XIIPotentially medulloblastoma (uncertain, limited evidence)

Beyond the preview

Go deeper on Calcium homeostasis modulator protein 3 (CALHM3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium homeostasis modulator protein 3 (CALHM3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call